Zerumbone Topical Composition for Vein Wall Tone
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for heavy or tired legs, characterized by venous stagnation and dilation, often lead to varicose veins and discomfort, with existing solutions failing to effectively address the underlying issues of vein wall tone and elasticity loss.
Innovation Solution
A topical composition containing zerumbone, which strengthens and preserves the extracellular matrix surrounding micro-capillaries by acting on elastin fibers and molecules like collagen, dermatopontine, fibromoduline, and cathepsin L, thereby improving vein wall tone and reducing inflammation and permeability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If topical treatments are applied to address venous stagnation and dilation, then circulation improvement is achieved, but vein wall tone and elasticity are not effectively restored
Solution Approach 1:
The patent introduces zerumbone as an intermediary substance that mediates between the topical application and the vein wall structures. Zerumbone acts on the extracellular matrix components (elastin fibers, collagen, dermatopontin, fibromodulin) surrounding micro-capillaries, thereby indirectly restoring vein wall tone and elasticity while improving circulation. This mediator approach resolves the contradiction by providing a substance that simultaneously addresses both circulation speed and structural strength.
Solution Approach 2:
The patent changes the chemical parameter by introducing zerumbone, a sesquiterpene compound with specific biochemical properties. This substance modifies the physical state of the extracellular matrix by acting on elastin and collagen structures, thereby changing the mechanical parameters (tone and elasticity) of the vein wall. The parameter change from chemical composition to mechanical property resolves the contradiction between circulation improvement and structural restoration.
2Speed
If existing treatments address venous stagnation, then circulation is improved, but underlying issues of vein wall structure are not resolved
Solution Approach 1:
The patent applies preliminary action by having zerumbone act on the extracellular matrix components before significant vein wall degradation occurs. By targeting elastin fibers, collagen, dermatopontin, and fibromodulin in the extracellular matrix surrounding micro-capillaries, the treatment prevents the progression to varicose veins and maintains vein wall integrity. This preventive approach addresses the underlying structural issues before they manifest as serious venous problems.
Solution Approach 2:
Zerumbone serves as an intermediary that connects blood flow improvement with structural integrity maintenance. It acts on the extracellular matrix components that provide structural support to veins, thereby ensuring that circulation improvements do not come at the expense of vein wall integrity. The intermediary substance bridges the gap between functional improvement and structural preservation.
3Object-affected harmful factors
If topical compositions are applied to treat heavy legs sensation, then discomfort is reduced, but extracellular matrix degradation is not prevented
Solution Approach 1:
The patent converts the harmful effect of extracellular matrix degradation into a benefit by using zerumbone to protect and preserve these structures. Instead of merely treating the symptoms (heaviness and discomfort), the treatment addresses the root cause (ECM degradation) by having zerumbone act on elastin, collagen, dermatopontin, and fibromodulin. This transforms the potential harm of matrix breakdown into the benefit of matrix preservation and vein wall strengthening.
Solution Approach 2:
Zerumbone acts as an intermediary substance that protects the extracellular matrix from degradation while simultaneously relieving heaviness and discomfort. It mediates between the structural components of the vein wall and the functional symptoms, ensuring that discomfort reduction does not occur at the expense of matrix stability. The intermediary protects the structural integrity while providing symptomatic relief.
Data Source
AI summary
The subject matter of the invention is the topical use of zerumbone preferably extracted from Zingiber zerumbet (L.) Smith for the treatment of the deficiencies of the capillary network of the skin, resulting in feelings of heaviness and tingling in the lower limbs. It also helps to treat micro-subcutaneous oedemas, including bags and/or dark circles under the eyes.